Internal Medicine, Endocrinology, Diabetes, & Metabolism · Weatherford, TX
NPI
1710197363
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
891 Eureka St
Weatherford, TX, 76086
Phone (817) 599-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$177K
4,973 services
Medicare patients, 2024
725
Average age 72
Drug cost, 2024
$8.8M
10,241 prescriptions
Company payments, 2025
$2,081
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad I Choudhry was code 99214 (office e&m - established), 1,263 times for 595 patients. In total Muhammad I Choudhry billed 4,973 services in 37 codes, and Medicare paid $177K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,263 | 595 | $85.21 | $108K |
| 82962 Clinical Chemistry | Office | 1,001 | 426 | $3.20 | $3,207 |
| 83036 Blood Count | Office | 788 | 365 | $9.51 | $7,493 |
| 95251 Test - Miscellaneous | Office | 313 | 151 | $24.12 | $7,548 |
| 36415 Venipuncture Blood Collection | Office | 297 | 179 | $4.89 | $1,451 |
| 84443 Clinical Chemistry | Office | 249 | 138 | $16.34 | $4,069 |
| 84439 Clinical Chemistry | Office | 248 | 139 | $8.78 | $2,176 |
| 84481 Clinical Chemistry | Office | 229 | 130 | $16.47 | $3,771 |
| 99204 Office E&M - New | Office | 203 | 203 | $116.66 | $24K |
| 99213 Office E&M - Established | Office | 72 | 51 | $59.72 | $4,300 |
| 83970 Clinical Chemistry | Office | 40 | 20 | $39.55 | $1,582 |
| 82310 Clinical Chemistry | Office | 35 | 20 | $5.06 | $177 |
| 82306 Clinical Chemistry | Office | 35 | 23 | $28.27 | $990 |
| 80053 Clinical Chemistry | Office | 33 | 30 | $10.35 | $342 |
| 10005 Other Organ Systems | Office | 27 | 24 | $98.98 | $2,673 |
By year: 2022 $161K for 4,102 services; 2023 $173K for 4,602 services; 2024 $177K for 4,973 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 1,001 | 426 | $3.20 | $3,207 |
| 83036 Blood Count | 788 | 365 | $9.51 | $7,493 |
| 36415 Venipuncture Blood Collection | 297 | 179 | $4.89 | $1,451 |
| 84443 Clinical Chemistry | 249 | 138 | $16.34 | $4,069 |
| 84439 Clinical Chemistry | 248 | 139 | $8.78 | $2,176 |
| 84481 Clinical Chemistry | 229 | 130 | $16.47 | $3,771 |
| 83970 Clinical Chemistry | 40 | 20 | $39.55 | $1,582 |
| 82306 Clinical Chemistry | 35 | 23 | $28.27 | $990 |
| 82310 Clinical Chemistry | 35 | 20 | $5.06 | $177 |
| 80053 Clinical Chemistry | 33 | 30 | $10.35 | $342 |
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad I Choudhry prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 1,146 prescriptions and refills. In total Muhammad I Choudhry wrote 10,241 Medicare prescriptions that cost $8.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 1,146 | 1,527 | 249 | $1.6M |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 662 | 921 | 127 | $649K |
| Levothyroxine Sodium Generic | 621 | 1,723 | 179 | $6,762 |
| Ozempic Semaglutide | 496 | 825 | 146 | $779K |
| Humalog Kwikpen U-200 Insulin Lispro | 371 | 503 | 83 | $737K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 332 | 598 | 77 | $342K |
| Liothyronine Sodium Generic | 287 | 731 | 89 | $9,306 |
| Pioglitazone Hcl Generic | 264 | 682 | 88 | $2,614 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 219 | 358 | 59 | $290K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 191 | 315 | 69 | $222K |
| V-Go 40 Sub-Q Insulin Device, 40 Unit | 178 | 229 | 49 | $121K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 161 | 411 | 74 | $14K |
| Glipizide-Metformin Glipizide/Metformin Hcl | 149 | 382 | 44 | $9,004 |
| Jardiance Empagliflozin | 147 | 330 | 41 | $190K |
| Pioglitazone-Glimepiride Pioglitazone Hcl/Glimepiride | 144 | 409 | 71 | $44K |
Brand drugs: 6,125 claims; generic drugs: 2,585 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad I Choudhry $2,081 ($2,081 in general payments such as food, travel and fees) from 28 companies. The largest payer was Amgen Inc. with $274.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 18 | $274 |
| Novo Nordisk Inc NVO | 10 | $168 |
| Abbott Laboratories ABT | 9 | $167 |
| Lilly USA, LLC LLY | 7 | $150 |
| Xeris Pharmaceuticals, Inc. | 7 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $136 |
| Endo USA, Inc. | 6 | $113 |
| Corcept Therapeutics CORT | 5 | $93.41 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $88.04 |
| Dexcom, Inc. DXCM | 4 | $85.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.